MDSAP Certification Route Extended to Brazilian, South American Medical Device Companies
Questions? Request more information from our specialists
CONTACT USFeb 27, 2018
EMERGO SUMMARY OF KEY POINTS:
- Brazilian regulators now allow domestic manufacturers to apply for quality system certification under the Medical Device Single Audit Program (MDSAP).
- Previously, ANVISA’s position was to recognize MDSAP certification only for foreign manufacturers.
Brazilian medical device market regulator ANVISA has officially extended applicability of the Medical Device Single Audit Program (MDSAP) to domestic manufacturers as well as other companies based in South America.
According to RDC 217.2018 (link in Portuguese), the MDSAP good manufacturing practice certification route is now open to medical device manufacturers based in Brazil, as well as to manufacturers based in South American countries belonging to the MERCOSUL trade group: Argentina, Paraguay and Uruguay.
Prior to RDC 217.2018, Brazil’s MDSAP certification route had only been available to foreign manufacturers registering with ANVISA. Now, domestic ANVISA registrants may also leverage MDSAP quality system certification for access to other participating markets—the US, Canada, Australia and Japan.
Related MDSAP and Brazilian medical device regulatory information:
- Brazil ANVISA medical device registration consulting
- Brazil GMP (BGMP) quality system compliance consulting
- On-site MDSAP training for medical device companies
- MDSAP compliance transition support
- Whitepaper: MDSAP certification pathway
- Whitepaper: Brazil ANVISA medical device registration
Author
- Stewart Eisenhart
Related
Brazilian ANVISA Clarifies Local, Federal Level Medical Device Oversight Responsibilities
EMERGO SUMMARY OF KEY POINTS:
- ANVISA has formally mapped out medical device regulatory responsibilities at its federal, state-level and local branches.
- Under RDC 215/2018, ANVISA oversight responsibilities and structures currently in place are mostly kept as is.
Brazil’s ANVISA Doubles Validity Timeframes for High-Risk Medical Devices and IVDs
EMERGO SUMMARY OF KEY POINTS:
- ANVISA has extended Class III and IV medical device and IVD registration validity times from five to 10 years.
- These changes have already gone into effect in Brazil.
- ANVISA registrants that have already obtained registration renewals will automatically qualify for the extended validity timeframe.